Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 

 

Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Aug 14, 2022

Jeff Beck is the Chief Development Officer at BioCareSD, a specialty pharmaceutical distributor. The field of specialty drugs has grown from the first drug for hemophilia in the 1980s to today, with about 50% of the drugs in the pipeline being specialty drugs. BioCareSD is an important component of the supply chain to ensure that these life-saving and life-sustaining drugs are available at the right time and in the right place.

Jeff explains, "I'm actually right now at the World Orphan Drug Conference, and it's unbelievable the number of studies that are underway for diseases that maybe a hundred people have, or a thousand people. What we're seeing now is more, and more of these patients are being able to live a really great life, no longer worried about having debilitating conditions. Sometimes, it's life-saving medicine. Sometimes, life-sustaining medicines. At BioCareSD, we're an important cog in the wheel to get those products to the patients."

"Specialty pharmaceuticals, it seems like the term has expanded a lot over the days. Sometimes you used to think that specialty pharmaceuticals were just infusible drugs, really high-cost drugs. There are specialty pharmaceuticals now that are pills, but they're unique. They're drugs that usually treat smaller patient populations, so I don't see them moving out of that niche or that term, so to speak."

@BioCareSD #BioCareSD #BioCare #SpecialtyDistribution #MedicalSupplyChain #RareDiseases #Pharmaceuticals

BioCareSD.com

Download the transcript here

BioCareSD